Elemis, the British prestige skin and spa brand, is closing in on a sale, with buyout firm Pai Partners in exclusive negotiations.
Elemis built its reputation in spas and hotel treatment rooms, a distribution model that gave it a premium halo long before clinical English skincare became fashionable.
The strategic appeal is clear: Elemis occupies a profitable middle — prestige pricing without the red-carpet associations of the French maisons, and a spa channel competitors cannot easily replicate.
For the wider skincare market, the sale is another signal that prestige beauty assets remain highly tradeable even as luxury demand cools.
